Research Article

Prevalence and Mortality Rates of Acute Kidney Injury among Critically Ill Patients: A Retrospective Study

Table 1

Baseline characteristics and factors contributing to the occurrence of AKI.

Baseline characteristicsTotal sample
N = 457
No AKI
N = 261
Developed AKI during MICU stay
N = 196
value

Age group0.72
 M ± SD63.8 ± 18.263.2 ± 17.664.2 ± 18.9
 18–60 years181 (39.6%)106 (58.6%)75 (41.4%)
 >60 years276 (60.4%)155 (56.2%)121 (43.8%)
Gender0.64
 Female226 (49.5%)127 (56.2%)99 (43.8%)
 Male231 (50.5%)134 (58.0%)97 (42.0%)
Smoking (yes %)69 (16.5%)47 (68.1%)22 (31.9%)0.03
Comorbidities
 Hypertension (yes %)269 (64.5%)140 (52.0%)129 (48.0%)0.002
 Diabetes mellitus (yes %)218 (52.3%)113 (51.8%)105 (48.2%)0.01
 Coronary artery disease (yes %)181 (43.4%)104 (57.5%)77 (42.5%)0.91
 Chronic pulmonary diseases (yes %)110 (25.4%)63 (57.3%)47 (42.7%)0.63
 Chronic kidney diseases GFR <60 (yes %)140 (33.6%)65 (46.4%)75 (53.6%)0.001
 Chronic liver diseases (yes %)26 (6.2%)16 (61.5%)10 (38.5%)0.72
 Endocrine (yes %)13 (3.6%)2 (15.4%)11 (84.6%)0.002
 Active malignancy (yes %)55 (13.2%)30 (54.6%)25 (45.5%)0.65
 Neurological disease (yes %)67 (16.1%)40 (59.7%)27 (40.3%)0.76
Cause of admission
 Acute pulmonary diseases157 (34.4%)97 (61.2%)60 (38.2%)0.06
 Acute gastroenterological diseases73 (16.2%)38 (52.0%)35 (48.0%)
 Acute neurological diseases54 (11.8%)34 (63.0%)20 (37.0%)
 Sepsis111 (24.3%)56 (50.4%)55 (49.5%)
 Acute cardiovascular diseases28 (6.2%)15 (53.6%)13 (46.4%)
 Endocrine disorders12 (2.6%)8 (66.7%)4 (33.3%)
 Others21 (4.6%)10 (47.6%)11 (52.4%)
Medications
 ACEI or ARB (yes %)104 (23.9%)69 (66.4%)35 (33.7%)0.03
 NSAIDs (yes %)66 (15.1%)29 (43.9%)37 (56.1%)0.02
 Aspirin (yes %)202 (46.3%)106 (52.5%)96 (47.5%)0.07
 Diuretics (yes %)232 (53.2%)134 (57.8%)98 (42.2%)0.83
 Statin (yes %)172 (39.4%)94 (54.7%)78 (45.4%)0.43
 PPI (yes %)328 (75.2%)188 (57.3%)140 (42.7%)0.91
Vital signs
 Systolic blood pressure (mmHg)135.3 ± 34.6135.7 ± 34.9134.8 ± 34.30.90
 Diastolic blood pressure (mmHg)73.2 ± 23.475.5 ± 22.070.2 ± 24.40.02
 MAP (mmHg)81.6 ± 38.683.5 ± 38.979.1 ± 38.30.24
 Heart rate91.8 ± 22.993.1 ± 23.990.15 ± 21.50.35
 Respiratory rate20.2 ± 3.120.2 ± 2.920.1 ± 3.30.91
Laboratory results
 Hemoglobin level11.2 ± 6.011.7 ± 7.610.6 ± 2.60.01
 White blood count11.6 ± 10.310.7 ± 7.012.65 ± 11.50.12
 Platelets count235.0 ± 124.2239.7 ± 129.3228.9 ± 117.20.53
 Serum sodium level139.1 ± 8.9139.1 ± 10.0139.2 ± 7.20.42
 Serum glucose170.9 ± 119.0170.7 ± 126.0171.1 ± 110.20.88
 Serum urea79.2 ± 65.054.9 ± 42.6110.8 ± 74.8<0.001
 Serum potassium4.4 ± 0.94.2 ± 0.74.6 ± 1.1<0.001
 Serum bicarbonate22.4 ± 7.224.0 ± 6.420.6 ± 7.6<0.001
 Serum PH7.38 ± 0.17.4 ± 0.17.36 ± 0.1<0.001
 Serum albumin3.3 ± 0.93.4 ± 1.13.22 ± 0.70.05
 Serum CRP100.9 ± 132.295.2 ± 129.3108.4 ± 135.80.46
 Serum creatinine1.1 + 1.10.9 + 0.81.2 + 1.40.03
 eGFR67.3 ± 26.672.6 ± 23.460.2 ± 28.9<0.001

AKI: acute kidney injury; ICU: intensive care unit; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; NSAIDs: nonsteroidal anti-inflammatory drugs; PPI: proton pump inhibitor; GFR: glomerular filtration rate; MAP: mean arterial pressure. value ≤0.05; value ≤0.01. The bold values are significant with one star <0.05, with two stars <0.001.